Vascular endothelial growth factor (VEGF), an important mediator of angiogenesis in both healthy and diseased tissues, is a crucial antitumor target. A study demonstrated that a single intravenous administration of AAV/VEGF-Trap led to long-term efficacy and permitted not only suppression of primary tumor growth but also prevention of pulmonary metastasis [68].